Field Safety Notices about Symbiq infusers (Lists 16026 and 16027)

According to Health Products Regulatory Authority, this field safety notices involved a device in Ireland that was produced by Hospira.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Event Country
  • Event Source
    HPRA
  • Event Source URL
  • Notes / Alerts
    Irish data is current through April 2019. All of the data comes from the Health Products Regulatory Authority (Ireland), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Ireland.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Extra notes in the data
    Advice has been provided by the manufacturer regarding a device modification. 3rd Party Publications

Device

  • Model / Serial
  • Product Description
    Symbiq infusers (Lists 16026 and 16027)
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Source
    HPRA